DK0520029T3 - Fremgangsmåde og forbindelse til behandling af maligne forekomster, hvortil der er knyttet en proteinkinase - Google Patents

Fremgangsmåde og forbindelse til behandling af maligne forekomster, hvortil der er knyttet en proteinkinase

Info

Publication number
DK0520029T3
DK0520029T3 DK91906924.5T DK91906924T DK0520029T3 DK 0520029 T3 DK0520029 T3 DK 0520029T3 DK 91906924 T DK91906924 T DK 91906924T DK 0520029 T3 DK0520029 T3 DK 0520029T3
Authority
DK
Denmark
Prior art keywords
treatment
malignant
instances
compound
attached
Prior art date
Application number
DK91906924.5T
Other languages
Danish (da)
English (en)
Inventor
Edmond H Fischer
Edwin G Krebs
Deborah E Cool
Nicholas K Tonks
Original Assignee
Washington Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Washington Res Found filed Critical Washington Res Found
Application granted granted Critical
Publication of DK0520029T3 publication Critical patent/DK0520029T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK91906924.5T 1990-03-14 1991-03-14 Fremgangsmåde og forbindelse til behandling af maligne forekomster, hvortil der er knyttet en proteinkinase DK0520029T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49403690A 1990-03-14 1990-03-14

Publications (1)

Publication Number Publication Date
DK0520029T3 true DK0520029T3 (da) 1995-10-16

Family

ID=23962758

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91906924.5T DK0520029T3 (da) 1990-03-14 1991-03-14 Fremgangsmåde og forbindelse til behandling af maligne forekomster, hvortil der er knyttet en proteinkinase

Country Status (9)

Country Link
EP (2) EP0627489B1 (de)
JP (1) JPH05505527A (de)
AT (2) ATE123064T1 (de)
CA (1) CA2078010A1 (de)
DE (2) DE69130117D1 (de)
DK (1) DK0520029T3 (de)
ES (1) ES2073165T3 (de)
GR (1) GR3017164T3 (de)
WO (1) WO1991013989A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE20010427A1 (en) * 1990-04-10 2003-03-05 Canji Inc Gene therapy for cell proliferative diseases
US5536636A (en) * 1991-06-26 1996-07-16 Beth Israel Hospital Methods for identifying a tyrosine phosphatase abnormality associated with neoplastic disease
GB9214754D0 (en) * 1992-07-10 1992-08-19 Univ Singapore Tumour treatment
MX9304769A (es) * 1992-08-05 1994-05-31 Max Planck Gesellschaft Subfamilia ptp-d de fosfatasas de la proteina tirosina.
AU6688696A (en) * 1995-08-10 1997-03-05 Incyte Pharmaceuticals, Inc. Non-receptor type human protein tyrosine phosphatase
WO1997035019A1 (en) * 1996-03-22 1997-09-25 Genentech, Inc. Protein tyrosine phosphatases of hematopoietic cells
US6238902B1 (en) 1996-03-22 2001-05-29 Genentech, Inc. Protein tyrosine phosphatases
US6248327B1 (en) 1998-09-11 2001-06-19 Vanderbilt University Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
US7176289B1 (en) 1998-09-11 2007-02-13 Vanderbilt University Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
US6485974B1 (en) * 2001-05-18 2002-11-26 Isis Pharmaceuticals, Inc. Antisense modulation of PTPN2 expression

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710469A (en) * 1986-05-02 1987-12-01 Merck & Co., Inc. Novel phosphotyrosyl protein phosphatase

Also Published As

Publication number Publication date
EP0627489A1 (de) 1994-12-07
JPH05505527A (ja) 1993-08-19
ES2073165T3 (es) 1995-08-01
DE69110034D1 (de) 1995-06-29
GR3017164T3 (en) 1995-11-30
WO1991013989A1 (en) 1991-09-19
EP0627489B1 (de) 1998-09-02
ATE123064T1 (de) 1995-06-15
CA2078010A1 (en) 1992-09-15
ATE170561T1 (de) 1998-09-15
DE69130117D1 (de) 1998-10-08
EP0520029B1 (de) 1995-05-24
DE69110034T2 (de) 1995-10-05
EP0520029A1 (de) 1992-12-30

Similar Documents

Publication Publication Date Title
DK0917571T3 (da) Hidtil ukendt agoutirelateret gen
ES2170366T3 (es) Secuencia de adn aislada del gen brca1 y su utilizacion en terapia antitumoral.
DE69824597D1 (de) Ikk-beta proteine, nukleinsäuren und verfahren
DE3588255D1 (de) Klonierung und Expression von HTLV-III-DNS
DE69111596D1 (de) Verwendung von zwitterionen zur mobilisierung isoelektrisch fokussierter ampholytzonen.
DK0520029T3 (da) Fremgangsmåde og forbindelse til behandling af maligne forekomster, hvortil der er knyttet en proteinkinase
DE69635482D1 (de) Säugetieren apoptosis inhibitorprotein genfamilie, primers, probes und verfahren zur nachweis
DE3587939D1 (de) Tumornekrosefaktor, Verfahren zu seiner Herstellung, denselben enthaltende Zusammensetzungen, dafür kodierende DNS und diese DNS verwendendes Testverfahren.
DE69333766D1 (de) Herstellung von phytat-degradierenden enzymen in trichoderma
ATE380195T1 (de) Zusammensetzungen und verfahren zur behandlung von tumoren
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
DE3585790D1 (de) Varicella-zoster-virus-dns-sequenzen, diese enthaltende vektoren und wirtzellen, uebereinstimmende polypeptide und diese enthaltende verbindungen.
IL92956A0 (en) Gene sequences which encode acylpeptide hydrolase and methods for detecting cancer utilizing the same
DE59805339D1 (de) Verfahren zum vergleich der kopienzahl von nukleinsäuresequenzen
DE69941273D1 (de) Zusammenstellung und Verfahren zur Diagnose von Tumoren
DE59712871D1 (de) Heterocyclische verbindungen und deren verwendung in der detektion von nucleinsäuren
DE69131112T2 (de) Verbesserung der Ausscheidung von Proteinen
DE69934017D1 (de) 2,6-beta-d-fruktanhydrolase enzym und verfahren zu dessen verwendung
NO950420D0 (no) Interferon endelse derav
ATE327334T1 (de) Atp- und nukleinsäure-bindendes protein mit helikase- und atpase eigenschaften
DE59902472D1 (de) Zusammensetzung zur induktion einer tumorspezifischen immunantwort, verfahren zu deren herstellung sowie verwendung der zusammensetzung zur behandlung von neoplasien
CA2347371A1 (en) HEMATOPOIETIC REGULATION FACTORS AND METHODS OF USE
EA199900339A1 (ru) Ген роста человека и область гена, ответственная за низкий рост
DE69729961D1 (de) Inhibitorprotein der dna-gyrase.
FI991173A (fi) Menetelmä syöpäriskin detektoimiseksi ja testipakkaus sitä varten